255 related articles for article (PubMed ID: 27227879)
1. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
Li L; Lei QS; Zhang SJ; Kong LN; Qin B
PLoS One; 2016; 11(5):e0156496. PubMed ID: 27227879
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
3. IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathway.
Lu X; Wang J; Jin X; Huang Y; Zeng W; Zhu J
Biomed Res Int; 2015; 2015():959684. PubMed ID: 25861653
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
5. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
[TBL] [Abstract][Full Text] [Related]
6. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
7. [The influence of HBV and its antigens on the expressions of JAK-STAT signal transduction pathway molecules and antiviral proteins of IFN alpha].
Guan SH; Yang K; Lu MJ; Lu YP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):440-4. PubMed ID: 22053375
[TBL] [Abstract][Full Text] [Related]
8. The USP18 cysteine protease promotes HBV production independent of its protease activity.
Li Y; Yao M; Duan X; Ye H; Li S; Chen L; Yang C; Chen Y
Virol J; 2020 Apr; 17(1):47. PubMed ID: 32248821
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile after knockdown of USP18 in Hepg2.2.15 cells.
Li L; Lei QS; Kong LN; Zhang SJ; Qin B
J Med Virol; 2017 Nov; 89(11):1920-1930. PubMed ID: 28369997
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.
Mitra B; Wang J; Kim ES; Mao R; Dong M; Liu Y; Zhang J; Guo H
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019054
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
13. Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression.
Liu X; Pang X; Wan Z; Zhao J; Gao Z; Deng H
J Clin Transl Hepatol; 2024 May; 12(5):443-456. PubMed ID: 38779516
[TBL] [Abstract][Full Text] [Related]
14. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
15. TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway.
Zhu X; Xie C; Li YM; Huang ZL; Zhao QY; Hu ZX; Wang PP; Gu YR; Gao ZL; Peng L
Cell Death Dis; 2016 Jun; 7(6):e2239. PubMed ID: 27253403
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication.
Pei R; Qin B; Zhang X; Zhu W; Kemper T; Ma Z; Trippler M; Schlaak J; Chen X; Lu M
J Innate Immun; 2014; 6(2):182-91. PubMed ID: 23867918
[TBL] [Abstract][Full Text] [Related]
17. JAK/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B.
Dong Y; Li X; Yu Y; Lv F; Chen Y
Life Sci; 2020 Jul; 252():117663. PubMed ID: 32302624
[TBL] [Abstract][Full Text] [Related]
18. Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Zhang M; Wu X; Lai F; Zhang X; Wu H; Min T
J Agric Food Chem; 2016 May; 64(20):4068-77. PubMed ID: 27144395
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.
Wu M; Xu Y; Lin S; Zhang X; Xiang L; Yuan Z
J Gen Virol; 2007 Dec; 88(Pt 12):3260-3269. PubMed ID: 18024894
[TBL] [Abstract][Full Text] [Related]
20. Silencing SIRT1 promotes the anti-HBV action of IFN-α by regulating Pol expression and activating the JAK-STAT signaling pathway.
Tang Q; Meng C; Liu Y; Cheng Y; Liu Y; Long Y; Sun S; Feng F
Int Immunopharmacol; 2023 Nov; 124(Pt B):110939. PubMed ID: 37741128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
